BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

New 2007 Genetix product guide out now - Cell biology portfolio expands with new applications

2 March 2007: The 2007 Genetix Product Guide (Genetix Ltd, New Milton, UK) is out now. With more than 100 pages describing the company’s breakthrough platforms, the guide is a valuable resource for the laboratory. ClonePix FL and CloneSelect Imager are presented along with dedicated reagents and consumables for the generation, selection and management of mammalian cell lines for biopharmaceutical and drug discovery.  

Applications described in the new guide, range from the stratification of cell populations based on growth rate, therapeutic protein secretion productivity or cell surface marker expression to automated confluence measurement and assessment of clonality.  

The Genetix product range also includes liquid handling systems for cell and media dispensing, colony pickers and automated microarray instrumentation.  

To request your copy of the 2007 Genetix Product Guide, call:

+44 (0)1425 624 600 or register at www.genetix.com  

A high resolution image is available from Richard Kent at Kapler Communications (email: richard@kapleronline.com) Please quote reference GEN/JOB/040

 Notes to Editors

Genetix delivers pioneering, technological breakthroughs that give customers the competitive edge to find the cells and push the boundaries in biopharmaceutical and clinical research. It supplies major international Pharmaceutical and Biotechnology companies involved in the drug discovery process including GSK, Merck, Genentech, Wyeth, Novartis, as well as many leading academic institutions world-wide.  

Genetix achievements have helped revolutionize cell biology, proteomics and genomics. The company made a significant contribution to the Human Genome Project by supplying high-throughput equipment to seven of the leading eight laboratories of the consortium. Today, through its R&D expertise and scientific resource, Genetix is committed to the continual development of innovative solutions to accelerate the rate of Translational Biology.  

Genetix is quoted on the London Stock Exchange (symbol GTX) and is based in New Milton, Hampshire, UK.   

Enquiries:                                                      Media enquiries

Genetix Limited                                      Kapler Communications Ltd

Hilary Latham, Marketing Manager             Richard Kent, Director

Tel: +44 (0) 1425 624 600                      Tel: +44 (0) 1480 471 117

hilary.latham@genetix.com                        richard@kapleronline.com

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.